Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 USD | +1.92% | +12.13% | +26.34% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.34% | 767M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- WVE Stock
- News Wave Life Sciences Ltd.
- Earnings Flash (WVE) WAVE LIFE SCIENCES USA Reports Q1 Revenue $12.9M, vs. Street Est of $38.6M